-
Hot Stock List: Histogenics Corporation (NASDAQ:HSGX), FibroGen (NASDAQ:FGEN), Crossroads Systems (NASDAQ:CRDS), BGC Partners (NASDAQ:BGCP), Five Prime Therapeutics (NASDAQ:FPRX)
On Thursday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.88. Histogenics Corporation (NASDAQ:HSGX), announced its financial and operational results for the first quarter ended March 31, 2015. For the first quarter of 2015, Histogenics reported a net loss of $(8.0) million, or $(0.60) per share, compared to a net loss of $(3.4) million, or $(5.90)…
-
Top News: Histogenics Corporation (NASDAQ:HSGX), Verizon Communications Inc. (NYSE:VZ), E-Commerce China Dangdang Inc. (NYSE:DANG), Newmont Mining Corporation (NYSE:NEM), MGM Resorts International (NYSE:MGM)
On Thursday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $9.09. Canaccord Genuity reaffirmed their buy rating on shares of Histogenics Corporation (NASDAQ:HSGX) in a report issued on Tuesday. They currently have a $16.50 target price on the stock. On Thursday shares of Verizon Communications Inc. (NYSE:VZ) closed at $49.01. Company’s sales growth for last 5…
-
Trader’s Watch List: Cancer Genetics (NASDAQ:CGIX), Histogenics Corporation (NASDAQ:HSGX), Acorda Therapeutics (NASDAQ:ACOR), eBay Inc. (NASDAQ:EBAY), New York & Company (NYSE:NWY)
On Monday shares of Cancer Genetics, Inc. (NASDAQ:CGIX) closed at $7.40. Company’s sales growth for last 5 years was 31.20%. On March 12, Cancer Genetics, Inc. (NASDAQ:CGIX) reported a 16 percent year-over-year increase in its fourth quarter revenues. The Sunnyvale, Calif.-based firm said that for the three months ended Dec. 31, 2014 it had revenues…
-
Top Morning News: Histogenics Corporation (NASDAQ:HSGX), Amtech Systems Inc. (NASDAQ:ASYS), Callon Petroleum Company (NYSE:CPE), Marriott Vacations Worldwide (NYSE:VAC), Span-America Medical Systems (NASDAQ:SPAN)
Histogenics Corporation (NASDAQ:HSGX), announced it will release its financial and operational results for the fourth quarter and full year ended December 31, 2014 on February 26, 2015 before the market opens. On Friday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $9.60. TheStreet downgraded shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell…
-
Hot Runners: Histogenics Corporation (NASDAQ:HSGX), Coherus Biosciences (NASDAQ:CHRS), Derma Sciences Inc. (NASDAQ:DSCI), VeriFone Systems (NYSE:PAY), Ameris Bancorp (NASDAQ:ABCB)
On Feb. 2, Histogenics Corporation (NASDAQ:HSGX) announced the appointment of David Gill to its board of directors and chairman of the audit committee. Mr. Gill is currently the Chief Financial Officer of EndoChoice, Inc., a medical device company which provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal (GI)…
-
Stock in News: Histogenics Corporation (NASDAQ:HSGX), ConocoPhillips (NYSE:COP), Intel Corporation (NASDAQ:INTC), CBRE Group (NYSE:CBG), The GEO Group (NYSE:GEO)
BTIG Research initiated coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report released on January 23, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.83. ConocoPhillips (NYSE:COP) announced a quarterly dividend of 73 cents per share,…
-
Active Movers: Immunomedics Inc. (NASDAQ:IMMU), Histogenics Corporation (NASDAQ:HSGX), JDS Uniphase Corporation (NASDAQ:JDSU), Toyota Motor Corporation (NYSE:TM), Oracle Corporation (NYSE:ORCL)
On Jan. 29, Immunomedics Inc. (NASDAQ:IMMU) announced that the United States District Court for the District of New Jersey in a putative class action lawsuit, styled Nasyrova v. Immunomedics, Inc., has granted the Company’s motion to dismiss the complaint in its entirety. On Thursday shares of Immunomedics Inc. (NASDAQ:IMMU) closed at $5.28. Company’s sales growth…
-
Biotech Stocks New Lows: Histogenics Corporation (NASDAQ:HSGX), Cleveland BioLabs (NASDAQ:CBLI), Theravance Inc. (NASDAQ:THRX), Celsion Corp. (NASDAQ:CLSN), VIVUS Inc. (NASDAQ:VVUS)
BTIG Research initiated coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report released on Friday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.11. Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that at a special meeting…
-
Stocks in Focus: Histogenics Corporation (NASDAQ:HSGX), TECO Energy (NYSE:TE), Johnson & Johnson (NYSE:JNJ), International Business Machines Corporation (NYSE:IBM), AT&T (NYSE:T)
Canaccord Genuity started coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report sent to investors on Monday morning,TheFlyOnTheWall.com reports. The firm issued a buy rating and a $16.50 price target on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $9.63. TECO Energy, Inc. (NYSE:TE) announced that the company will host…